# Gene polymorphism Mu opioid receptor & its impact on naltrexone treatment response in alcohol-dependent individuals: A pilot study from north India

## Metadata
**Authors:** Rizwana Quraishi, Ram Kumar, Siddharth Sarkar, Ravindra Rao, Atul Ambekar
**Journal:** The Indian Journal of Medical Research
**Date:** 2025 Mar 26
**DOI:** [10.25259/IJMR_141_2024](https://doi.org/10.25259/IJMR_141_2024)
**PMID:** 40257143
**PMCID:** PMC12010784
**URL:** https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12010784/
**PDF:** [https://pmc.ncbi.nlm.nih.gov/articles/PMC12010784/pdf/IJMR-161-2-199.pdf](https://pmc.ncbi.nlm.nih.gov/articles/PMC12010784/pdf/IJMR-161-2-199.pdf)

## Acknowledgment

Authors acknowledge the Biochemistry laboratory staff at National Drug Dependence Treatment Centre, All India Institute of Medical Sciences, New Delhi for providing technical assistance to carry out this study.

## Financial support & sponsorship

Authors would like to thank Indian Council of Medical Research for providing financial support (Ref no: 5/4-4/123/M/2015-NCD-I).

## Conflicts of Interest

None.

## Use of Artificial Intelligence (AI)-Assisted Technology for manuscript preparation

The authors confirm that there was no use of AI-assisted technology for assisting in the writing of the manuscript and no images were manipulated using AI.

## References

1. Ambekar A, Kattimani S. Anti-Craving Medications in the Treatment of Alcoholism. In: Dhawan A, Jhanjee S, editors. Manual for long term pharmacotherapy. National Drug Dependence Treatment Centre, All India Institute of Medical Sciences, developed under WHO, Ministry of Health & Family Welfare, Government of India; 2006. pp. 13–23.  [Google Scholar](https://scholar.google.com/scholar_lookup?title=Manual%20for%20long%20term%20pharmacotherapy&author=A%20Ambekar&author=S%20Kattimani&publication_year=2006&)

2. Del Re A, Maisel N, Blodgett J, Finney J. The declining efficacy of naltrexone pharmacotherapy for alcohol use disorders over time: A multivariate meta-analysis. Alcohol Clin Exp Res. 2013;37:1064–8. doi: 10.1111/acer.12067.  [DOI](https://doi.org/10.1111/acer.12067) | [PMC free article](/articles/PMC3657572/) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/23398164/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Alcohol%20Clin%20Exp%20Res&title=The%20declining%20efficacy%20of%20naltrexone%20pharmacotherapy%20for%20alcohol%20use%20disorders%20over%20time:%20A%20multivariate%20meta-analysis&author=A%20Del%20Re&author=N%20Maisel&author=J%20Blodgett&author=J%20Finney&volume=37&publication_year=2013&pages=1064-8&pmid=23398164&doi=10.1111/acer.12067&)

3. Chamorro A, Marcos M, Mirón-Canelo J, Pastor I, González-Sarmiento R, Laso F. Association of µ-opioid receptor (OPRM1) gene polymorphism with response to naltrexone in alcohol dependence: A systematic review and meta-analysis. Addict Biol. 2012;17:505–12. doi: 10.1111/j.1369-1600.2012.00442.x.  [DOI](https://doi.org/10.1111/j.1369-1600.2012.00442.x) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/22515274/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Addict%20Biol&title=Association%20of%20%C2%B5-opioid%20receptor%20(OPRM1)%20gene%20polymorphism%20with%20response%20to%20naltrexone%20in%20alcohol%20dependence:%20A%20systematic%20review%20and%20meta-analysis&author=A%20Chamorro&author=M%20Marcos&author=J%20Mir%C3%B3n-Canelo&author=I%20Pastor&author=R%20Gonz%C3%A1lez-Sarmiento&volume=17&publication_year=2012&pages=505-12&pmid=22515274&doi=10.1111/j.1369-1600.2012.00442.x&)

4. Ambekar A, Agrawal A, Rao R, Mishra AK, Khandelwal SK, Chadda RK. on behalf of the group of investigators for the National Survey on Extent and Pattern of Substance use in India . Magnitude of substance use in India. New Delhi: Ministry of Social Justice and Empowerment, Government of India; 2019.  [Google Scholar](https://scholar.google.com/scholar_lookup?title=Magnitude%20of%20substance%20use%20in%20India&author=A%20Ambekar&author=A%20Agrawal&author=R%20Rao&author=AK%20Mishra&author=SK%20Khandelwal&publication_year=2019&)

5. Anton R, Oroszi G, O’Malley S, Couper D, Swift R, Pettinati H, et al. An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: Results from the combined pharmacotherapies and behavioral interventions for alcohol dependence (COMBINE) study Arch Gen Psychiatry200865135–44.  [DOI](https://doi.org/10.1001/archpsyc.65.2.135) | [PMC free article](/articles/PMC2666924/) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/18250251/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Arch%20Gen&title=An%20evaluation%20of%20mu-opioid%20receptor%20(OPRM1)%20as%20a%20predictor%20of%20naltrexone%20response%20in%20the%20treatment%20of%20alcohol%20dependence:%20Results%20from%20the%20combined%20pharmacotherapies%20and%20behavioral%20interventions%20for%20alcohol%20dependence%20(COMBINE)%20study&author=R%20Anton&author=G%20Oroszi&author=S%20O%E2%80%99Malley&author=D%20Couper&author=R%20Swift&volume=65&publication_year=2008&pages=135-44&pmid=18250251&doi=10.1001/archpsyc.65.2.135&)

6. De Sousa A, De Sousa A. A one-year pragmatic trial of naltrexone vs disulfiram in the treatment of alcohol dependence. Alcohol Alcohol. 2004;39:528–31. doi: 10.1093/alcalc/agh104.  [DOI](https://doi.org/10.1093/alcalc/agh104) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/15525790/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Alcohol%20Alcohol&title=A%20one-year%20pragmatic%20trial%20of%20naltrexone%20vs%20disulfiram%20in%20the%20treatment%20of%20alcohol%20dependence&author=A%20De%20Sousa&author=A%20De%20Sousa&volume=39&publication_year=2004&pages=528-31&pmid=15525790&doi=10.1093/alcalc/agh104&)

7. Kumar R, Quraishi R, Sarkar S, Rao R, Ambekar A. Naltrexone and its effects on craving and alcohol use among patients with alcohol dependence syndrome: A report. Addict Health. 2024;16:224–7. doi: 10.34172/ahj.1494.  [DOI](https://doi.org/10.34172/ahj.1494) | [PMC free article](/articles/PMC11491863/) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/39439852/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Addict%20Health&title=Naltrexone%20and%20its%20effects%20on%20craving%20and%20alcohol%20use%20among%20patients%20with%20alcohol%20dependence%20syndrome:%20A%20report&author=R%20Kumar&author=R%20Quraishi&author=S%20Sarkar&author=R%20Rao&author=A%20Ambekar&volume=16&publication_year=2024&pages=224-7&pmid=39439852&doi=10.34172/ahj.1494&)

8. Deb I, Chakraborty J, Gangopadhyay P, Choudhury S, Das S. Single-nucleotide polymorphism (A118G) in exon 1 of OPRM1 gene causes alteration in downstream signaling by mu-opioid receptor and may contribute to the genetic risk for addiction. J Neurochem. 2010;112:486–96. doi: 10.1111/j.1471-4159.2009.06472.x.  [DOI](https://doi.org/10.1111/j.1471-4159.2009.06472.x) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/19891732/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=J%20Neurochem&title=Single-nucleotide%20polymorphism%20(A118G)%20in%20exon%201%20of%20OPRM1%20gene%20causes%20alteration%20in%20downstream%20signaling%20by%20mu-opioid%20receptor%20and%20may%20contribute%20to%20the%20genetic%20risk%20for%20addiction&author=I%20Deb&author=J%20Chakraborty&author=P%20Gangopadhyay&author=S%20Choudhury&author=S%20Das&volume=112&publication_year=2010&pages=486-96&pmid=19891732&doi=10.1111/j.1471-4159.2009.06472.x&)
